1 | at vero eos et | | | | | | | 3 | 0.55% |
2 | vero eos et accusamus | | | | | | | 3 | 0.55% |
3 | eos et accusamus et | | | | | | | 3 | 0.55% |
4 | et accusamus et iusto | | | | | | | 3 | 0.55% |
5 | accusamus et iusto odio | | | | | | | 3 | 0.55% |
6 | et iusto odio dignissimos | | | | | | | 3 | 0.55% |
7 | iusto odio dignissimos ducimus | | | | | | | 3 | 0.55% |
8 | odio dignissimos ducimus qui | | | | | | | 3 | 0.55% |
9 | sign up for our | | | | | | | 1 | 0.18% |
10 | with billions of ultrasound | | | | | | | 1 | 0.18% |
11 | scans with billions of | | | | | | | 1 | 0.18% |
12 | of ultrasound loop images | | | | | | | 1 | 0.18% |
13 | multinational scans with billions | | | | | | | 1 | 0.18% |
14 | of multinational scans with | | | | | | | 1 | 0.18% |
15 | on hundreds of thousands | | | | | | | 1 | 0.18% |
16 | trained on hundreds of | | | | | | | 1 | 0.18% |
17 | were trained on hundreds | | | | | | | 1 | 0.18% |
18 | models were trained on | | | | | | | 1 | 0.18% |
19 | ai models were trained | | | | | | | 1 | 0.18% |
20 | stateoftheart ai models were | | | | | | | 1 | 0.18% |
21 | our stateoftheart ai models | | | | | | | 1 | 0.18% |
22 | billions of ultrasound loop | | | | | | | 1 | 0.18% |
23 | our algorithms have been | | | | | | | 1 | 0.18% |
24 | for your institution and | | | | | | | 1 | 0.18% |
25 | superior level of accuracy | | | | | | | 1 | 0.18% |
26 | organs anywhere and anytime | | | | | | | 1 | 0.18% |
27 | multiple organs anywhere and | | | | | | | 1 | 0.18% |
28 | of multiple organs anywhere | | | | | | | 1 | 0.18% |
29 | diagnosis of multiple organs | | | | | | | 1 | 0.18% |
30 | infrastructure to support instant | | | | | | | 1 | 0.18% |
31 | technological infrastructure to support | | | | | | | 1 | 0.18% |
32 | scalable technological infrastructure to | | | | | | | 1 | 0.18% |
33 | a scalable technological infrastructure | | | | | | | 1 | 0.18% |
34 | bringing a scalable technological | | | | | | | 1 | 0.18% |
35 | of patients with a | | | | | | | 1 | 0.18% |
36 | algorithms have been clinically | | | | | | | 1 | 0.18% |
37 | thousands of patients with | | | | | | | 1 | 0.18% |
38 | on thousands of patients | | | | | | | 1 | 0.18% |
39 | trials on thousands of | | | | | | | 1 | 0.18% |
40 | prospective trials on thousands | | | | | | | 1 | 0.18% |